Physician profile
Alexander E Weber
NPI 1366763138
$81,766.04
in general payments reported to CMS, 2019-2025
9 companies · $8,593 in 2025
The $8,593 reported for 2025 was more than what 86% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $8,633 · 2021: $14K · 2022: $16K · 2023: $15K · 2024: $18K · 2025: $8,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $2,336 · Food and Beverage: $2,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,475.00 |
| Travel and Lodging | $2,335.72 |
| Food and Beverage | $2,112.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $72,332.40 | 2019-2025 | Insignia, Na, Aequalis |
| Arthrex, INC. | $8,592.61 | 2020 | |
| Pinnacle, INC | $218.48 | 2019 | |
| Boston Scientific Corporation | $164.99 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $164.54 | 2019-2021 | |
| Saxum Surgical, INC. | $135.25 | 2023 | |
| Djo, LLC | $93.75 | 2025 | Aircast, Donjoy |
| Micromed INC | $40.00 | 2020 | |
| Vericel Corporation | $24.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.